Skip to content

King Pharmaceuticals KG Workers' Compensation — Year 2

Other product segments

All other lines
32.4%
Commercial Auto Liability
17.6%
General Liability
10.4%
European Hospital Liability
7.1%
International
6.9%

Similar metrics at other companies

Old Republic International logo
ORIWorkers' Compensation — Year 2
24.1%-0.2pp
CNA Financial logo
CNAWorkers' Compensation — Year 2
24.2%+0.8pp
United Fire Group logo
UFCSCommercial workers' compensation — Year 2
31.7%+0.3pp
The Hartford Financial Services Group logo
HIGWorkers' Compensation — 2nd Year
18.6%+0.2pp
Old Republic International logo
ORIWorkers' Compensation — Year 1
16.8%+0.3pp
PRA
PRAWorkers' Compensation Insurance — Historical claims duration, year 2 (percent)
39.7%+0.3pp

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — year 2.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — year 2?
King Pharmaceuticals (KG) reported workers' compensation — year 2 of 32.5% in Q4 2025.
What does workers' compensation — year 2 mean?
This metric tracks the financial performance or claim activity for the second year of the workers' compensation policy cycle. It provides insight into the maturation of claims and the accuracy of initial loss estimates made in the first year. Analyzing this data is critical for understanding the development of loss ratios over time.